Clinical trials
Recruiting Phase 3 Migraine Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 4 |
| 2022 | 3 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| AbbVie | 2 |
| Kallyope Inc. | 2 |
| Columbia University | 1 |
| H. Lundbeck A/S | 1 |
| Oslo University Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| University Health Network, Toronto | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Migraine Disorders | 13 |
| Hyperacusis | 3 |
| Nausea | 3 |
| Photophobia | 3 |
| Headache Disorders | 2 |
| Chronic Pain | 1 |
| Foramen Ovale, Patent | 1 |
| Mitochondrial Diseases | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.